Skip to Content

ULTRA Fel-O-Vax FVRCP + FeLV

This page contains information on ULTRA Fel-O-Vax FVRCP + FeLV for veterinary use.
The information provided typically includes the following:
  • ULTRA Fel-O-Vax FVRCP + FeLV Indications
  • Warnings and cautions for ULTRA Fel-O-Vax FVRCP + FeLV
  • Direction and dosage information for ULTRA Fel-O-Vax FVRCP + FeLV

ULTRA Fel-O-Vax FVRCP + FeLV

This treatment applies to the following species:
Manufacturer: Boehringer Ingelheim

Feline Leukemia-Rhinotracheitis-Calici-Panleukopenia Vaccine

Killed Virus

Veterinary Use Only

For subcutaneous vaccination of healthy cats 8 to 10 weeks of age or older, as an aid in the prevention of disease caused by feline leukemia, rhinotracheitis, calici and panleukopenia viruses. The vaccine contains one additional feline calicivirus strain isolated from one hemorrhagic calicivirus outbreak that occurred in 1998 and was shown to protect vaccinated cats against calicivirus-induced hemorrhagic disease in controlled vaccination challenge experiments.

Dose: Inject one 0.5 mL dose subcutaneously using aseptic technique. Repeat in 3 to 4 weeks. Annual revaccination with a single dose of vaccine is recommended.

The PEEL-OFF LABEL I.D. SYSTEM provides a simple and effective method of recording pertinent information on the vaccines administered to animals in a veterinary practice.

For vaccines requiring reconstitution, remove label from both vials and affix both labels to the animal’s medical chart.

Using the System:

1.

Grasp the vial label at the corner marked with an indicator arrow, between your thumb and forefinger (figure 1).

2.

Pull steadily at a slight angle until the label is separated from the vial (figure 2).

3.

Place the label on the animal’s medical chart. Press down on the label to ensure adhesion.

ULTRA Fel-O-Vax FVRCP + FeLV Caution

Store in the dark at 2° to 7°C (35° to 45°F). Avoid freezing. Shake well. A small percentage of patients may experience transient lethargy, pyrexia and anorexia, and some cats may show transient discomfort (such as stinging, itching or pain) at the injection site. In exceptional circumstances, hypersensitivity or anaphylaxis may occur, requiring appropriate symptomatic treatment.

Thimerosal, neomycin, polymyxin B and amphotericin B added as preservatives.

ULTRA Fel-O-Vax FVRCP + FeLV Caution

In the absence of a veterinarian-client-patient relationship, Federal law prohibits the relabeling, repackaging, resale, or redistribution of the individual contents of this package.

ULTRA™ Fel-O-Vax® is a trademark of Boehringer Ingelheim Vetmedica, Inc.

U.S. Patent Nos. 6,042,835; 7,264,816; 7,306,807; 7,309,495; 7,449,323 used under license

© 2014 Boehringer Ingelheim Vetmedica, Inc. All rights reserved.

Boehringer Ingelheim Vetmedica, Inc., St. Joseph, MO 64506 U.S.A.

US Vet. Lic. No. 124

25 Doses

25 x 0.5 mL Vials of Vaccine

169502-01

NAC No.: 1028297.0

BOEHRINGER INGELHEIM VETMEDICA, INC.
2621 NORTH BELT HIGHWAY, ST. JOSEPH, MO, 64506-2002
Telephone:   800-325-9167
Fax:   816-236-2717
Website:   www.bevaccinesmart.com
    www.bi-vetmedica.com
    www.biviultraduramune.com
    www.bividollarsandsense.com
    www.bronchi-shieldoral.com
    www.duramunelepto.com
    www.duramunelyme.com
    www.haveweseenyourcatlately.com
    www.metacam.com
    www.mycathasdiabetes.com
    www.productionvalues.us
    www.prrsresearch.com
    www.prozinc.us
    www.vetera-vaccines.com
    www.vetmedin-us.com
    www.yourdogsheart.com
Email:   info@productionvalues.us
Every effort has been made to ensure the accuracy of the ULTRA Fel-O-Vax FVRCP + FeLV information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2016 North American Compendiums. Updated: 2016-10-31

Hide